Biomembranes serve barrier functions and serve as a store for precurso
rs of rapidly generated, structurally diverse intracellular and extrac
ellular lipid-derived mediators (LM). Cell activation is accompanied b
y remodeling of membrane components that appear to be essential in sig
nal transduction. Phospholipases (PLA(2), PLC, PLD, sphingomyelinase)
are pivotal in the generation of these LM including eicosanoids, plate
let activating factor (PAF), diacylglycerides, ceramide, and other new
ly discovered bioactive autacoids. Cytokines exert a dramatic multilev
el impact both in regulating enzymes in individual LM pathways and in
generating LM central to their action. Here, we provide an overview an
d update of recent progress in this area with emphases on the effect o
f cytokines on LM networks. The generation of eicosanoids (prostagland
ins, leukotrienes, and lipoxins), oxygenated lipids, and PAF remain th
e focus of rational drug design targets given their established roles
in cell-cell communication and as mediators in inflammation and pathop
hysiologic events. Key enzymes in these pathways are cloned, sequenced
, and their subcellular organization is investigated with surprising f
indings implicating involvement of the nuclear membrane at the functio
nal level. Several LM receptors are identified and cloned, and results
from transgenic animals have emerged for several key enzymes. Novel b
ioactive eicosanoids were discovered, including 15-epi-lipoxins, isopr
ostanes, and isoleukotrienes, that offered new concepts to consider in
formation of LM and the actions of nonsteroidal anti-inflammatory dru
gs. Together, these findings indicate that LM play critical and essent
ial roles in both signal transduction and cell-cell communication and
will continue to be important pathways to be considered in novel thera
peutic approaches.